Combining chemotherapy with new drugs that target a protein that helps cancer cells withstand chemotherapy could improve treatment.
New compound that locks a disease-related protein into an inactive position stifled the growth of an aggressive form of leukemia.
Scientists have discovered that a common drug given to arthritis sufferers could also help to treat patients with blood cancers.
T cells from patients with melanoma can trigger a protective immune response against the disease.
Small number of occult malignancies subsequently diagnosed among pregnant women whose results showed chromosomal abnormalities.
A sensor chip, able to pick up on differences in glycoprotein molecules, can improve accuracy and efficiency of prostate cancer diagnosis.
A recently developed drug holds great promise for some children with acute lymphoblastic leukemia (ALL).
A new potential treatment for a rare but previously incurable form of lymphoma that is observed primarily in patients with HIV/AIDS.
A comprehensive lung cancer screening program that utilizes CT scan technology could offer smokers a more accurate way to detect possible lung cancer.
In recent years, an increasing number of cancer patients were found to be assigning durable power of attorney.
- In breast cancer survivors, lidocaine may relieve pain during intercourse
- Likelihood of lung cancer screening update
- Generic meds may boost survival in some early breast cancers
- Aromatase inhibitors substantially reduce risk of death in ER-positive breast cancer
- Activated T cell therapy developed for advanced melanoma
- St. John's wort: natural does not necessarily mean safe
- No association between opioids, breast cancer recurrence
- Researchers, providers need to address cancer health care disparities in LGBTQ community
- New combination could make cancer more sensitive to chemotherapy
- New approach to treating B-cell acute lymphoblastic leukemia shows promise
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|